Leukotrienes

arachidonate 5-lipoxygenase ; Homo sapiens







526 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 29229677 Apoptotic Cancer Cells Suppress 5-Lipoxygenase in Tumor-Associated Macrophages. 2018 Jan 15 3
52 29805660 Association between 5-lipoxygenase expression, and malignant behaviors and poor prognosis in esophageal squamous cell carcinoma. 2018 Jun 2
53 29890138 Profiling of bioactive lipids in different dendritic cell subsets using an improved multiplex quantitative LC-MS/MS method. 2018 Oct 7 1
54 29928483 miR-146a suppresses 5-lipoxygenase activating protein (FLAP) expression and Leukotriene B4 production in lung cancer cells. 2018 Jun 1 1
55 30015253 Structural insight into the optimization of ethyl 5-hydroxybenzo[g]indol-3-carboxylates and their bioisosteric analogues as 5-LO/m-PGES-1 dual inhibitors able to suppress inflammation. 2018 Jul 15 1
56 30053720 Discovery of a benzenesulfonamide-based dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase that favorably modulates lipid mediator biosynthesis in inflammation. 2018 Aug 5 2
57 30248405 Targeting cysteinyl-leukotrienes in abdominal aortic aneurysm. 2018 Nov 2
58 30254055 MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity. 2018 Sep 25 1
59 30392579 5-lipoxygenase-dependent biosynthesis of novel 20:4 n-3 metabolites with anti-inflammatory activity. 2018 Nov 1
60 27883201 Effect of treatment with 5-lipoxygenase inhibitor VIA-2291 (atreleuton) on coronary plaque progression: a serial CT angiography study. 2017 Apr 1
61 28005436 Novel leukotriene biosynthesis inhibitors (2012-2016) as anti-inflammatory agents. 2017 May 2
62 28125014 Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase Pathway. 2017 Jan 24 1
63 28218273 Discovery of the first dual inhibitor of the 5-lipoxygenase-activating protein and soluble epoxide hydrolase using pharmacophore-based virtual screening. 2017 Feb 20 2
64 28257804 Characterization and cellular localization of human 5-lipoxygenase and its protein isoforms 5-LOΔ13, 5-LOΔ4 and 5-LOp12. 2017 May 1
65 28569429 CarbORev-5901: The First Carborane-Based Inhibitor of the 5-Lipoxygenase Pathway. 2017 Jul 6 1
66 28623130 Leukotriene signaling via ALOX5 and cysteinyl leukotriene receptor 1 is dispensable for in vitro growth of CD34+CD38- stem and progenitor cells in chronic myeloid leukemia. 2017 Aug 19 2
67 28647490 Sex-biased eicosanoid biology: Impact for sex differences in inflammation and consequences for pharmacotherapy. 2017 Dec 1 1
68 28680195 New Hydroxycinnamic Acid Esters as Novel 5-Lipoxygenase Inhibitors That Affect Leukotriene Biosynthesis. 2017 2
69 28803964 TGFβ/SMAD signalling modulates MLL and MLL-AF4 mediated 5-lipoxygenase promoter activation. 2017 Nov 2
70 28839250 Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase. 2017 Aug 24 3
71 26396238 Time-resolved in situ assembly of the leukotriene-synthetic 5-lipoxygenase/5-lipoxygenase-activating protein complex in blood leukocytes. 2016 Jan 3
72 26456699 The lipoxygenase pathway in zebrafish. Expression and characterization of zebrafish ALOX5 and comparison with its human ortholog. 2016 Jan 1
73 26541818 The natural dual cyclooxygenase and 5-lipoxygenase inhibitor flavocoxid is protective in EAE through effects on Th1/Th17 differentiation and macrophage/microglia activation. 2016 Mar 1
74 26549540 Regulation of tumorigenic Wnt signaling by cyclooxygenase-2, 5-lipoxygenase and their pharmacological inhibitors: A basis for novel drugs targeting cancer cells? 2016 Jan 1
75 26904397 Structural optimization and biological evaluation of 1,5-disubstituted pyrazole-3-carboxamines as potent inhibitors of human 5-lipoxygenase. 2016 Jan 3
76 26944113 Arachidonate 5-lipoxygenase (ALOX5) gene polymorphism is associated with Alzheimer's disease and body mass index. 2016 Mar 15 2
77 26979937 Cysteinyl leukotriene 1 receptor influences intestinal polyp incidence in a gender-specific manner in the ApcMin/+ mouse model. 2016 May 1
78 27010627 Structural and Functional Analysis of Calcium Ion Mediated Binding of 5-Lipoxygenase to Nanodiscs. 2016 1
79 27033421 Impact of simultaneous stimulation of 5-lipoxygenase and myeloperoxidase in human neutrophils. 2016 Apr 1
80 27157409 The 5-lipoxygenase inhibitor RF-22c potently suppresses leukotriene biosynthesis in cellulo and blocks bronchoconstriction and inflammation in vivo. 2016 Jul 15 2
81 27347071 Targeted deep resequencing of ALOX5 and ALOX5AP in patients with diabetes and association of rare variants with leukotriene pathways. 2016 Jul 4
82 27363940 Kinetic investigation of human 5-lipoxygenase with arachidonic acid. 2016 Aug 1 1
83 27423639 Synthesis and biological evaluation of C(5)-substituted derivatives of leukotriene biosynthesis inhibitor BRP-7. 2016 Oct 21 1
84 27592027 BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly. 2016 Nov 1 4
85 27635633 A Novel Inhibitor of 5-Lipoxygenase (5-LOX) Prevents Oxidative Stress-Induced Cell Death of Retinal Pigment Epithelium (RPE) Cells. 2016 Sep 1 2
86 27708579 Pharmacogenomics of Prostaglandin and Leukotriene Receptors. 2016 1
87 27855198 Identification and Characterization of a New Protein Isoform of Human 5-Lipoxygenase. 2016 1
88 27990118 Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association Studies. 2016 2
89 29648709 INHIBITORS OF LEUKOTRIENES SYNTHESIS: NOVEL AGENTS AND THEIR IMPLEMENTATION. 2016 Jul 2
90 24662827 Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltration. 2015 Mar 5 2
91 25152163 5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease. 2015 Apr 3
92 25462262 Development and evaluation of ST-1829 based on 5-benzylidene-2-phenylthiazolones as promising agent for anti-leukotriene therapy. 2015 Jan 7 1
93 25589070 5-lipoxygenase is a direct target of miR-19a-3p and miR-125b-5p. 2015 Feb 15 1
94 25681061 Progesterone rapidly down-regulates the biosynthesis of 5-lipoxygenase products in human primary monocytes. 2015 Apr 2
95 25733811 Design, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agents. 2015 1
96 25752438 A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome. 2015 May 1
97 25912480 Impact of myeloperoxidase-derived oxidants on the product profile of human 5-lipoxygenase. 2015 Aug 2
98 26040270 Synthesis and Biological Evaluation of N-Aryl-5-aryloxazol-2-amine Derivatives as 5-Lipoxygenase Inhibitors. 2015 2
99 26070487 5-Lipoxygenase is a direct p53 target gene in humans. 2015 Aug 2
100 26173130 The Intracellular Localisation and Phosphorylation Profile of the Human 5-Lipoxygenase Δ13 Isoform Differs from That of Its Full Length Counterpart. 2015 2